← Leaderboards
Kevin E Healy
University Of California Berkeley
$19,082,982
Attributed
$41,615,713
Total exposure
18
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$41,615,713 · 18
By mechanism
R01$12,383,011 · 7
U24$11,961,481 · 1
UH3$9,791,212 · 2
UG3$2,346,696 · 1
UH2$1,821,557 · 1
T32$1,760,155 · 1
Top collaborators
- David V Schaffer11 shared
- Andreas Stahl9 shared
- Matthias Hebrok5 shared
- Edward C Hsiao5 shared
- Luke P. Lee5 shared
- Holger Willenbring5 shared
- Bruce R Conklin4 shared
- Yang Chai3 shared
Most similar at University Of California Berkeley
Same institution · by research overlap
- Christine Frances Wildsoet$7,292,496
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsTissue EngineeringBasePharmaceutical PreparationsStem CellsSignal TransductionAnimal ModelIn VitroResponseBiologicalDesignInduced Pluripotent Stem CellDevicesStructureDiabetes MellitusCommunitiesPhenotypeComplexStemEngineeringTechnologyExtracellular MatrixIn Vitro Model
Grant awards (68)
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$2,287,847
UH3 · FY2022 · DK
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$2,294,476
UH3 · FY2021 · DK
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$2,305,521
UH3 · FY2020 · DK
Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity$578,025
R01 · FY2020 · HL · contact PI
Stem Cell Biological Engineering Training Program$213,885
T32 · FY2020 · GM
Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR)$3,970,932
U24 · FY2019 · DE
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$1,170,825
UG3 · FY2019 · DK
Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity$578,025
R01 · FY2019 · HL · contact PI
Stem Cell Biological Engineering Training Program$247,208
T32 · FY2019 · GM
Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR)$3,978,064
U24 · FY2018 · DE
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$1,175,871
UG3 · FY2018 · DK
Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity$578,025
R01 · FY2018 · HL · contact PI
Stem Cell Biological Engineering Training Program$244,020
T32 · FY2018 · GM
Stem Cell Biological Engineering Training Program$86,400
T32 · FY2018 · GM
Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR)$4,012,485
U24 · FY2017 · DE
Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity$592,275
R01 · FY2017 · HL · contact PI
Matrix assisted cell transplantation of brown fat$419,528
R01 · FY2017 · DK
Stem Cell Biological Engineering Training Program$160,606
T32 · FY2017 · GM
Disease-Specific Integrated Microphysiological Human Tissue Models$805,856
UH3 · FY2016 · TR · contact PI
Matrix assisted cell transplantation of brown fat$419,528
R01 · FY2016 · DK
Modeling a Rare Autonomic Disease$183,076
UH3 · FY2016 · TR · contact PI
Stem Cell Biological Engineering Training Program$158,584
T32 · FY2016 · GM
Modeling metabolic interactions of liver and fat with integrated microphysiological systems$157,023
UH3 · FY2016 · TR · contact PI
iPSC Derived Cardiac Microchambers for Embryonic Drug Screening$117,750
R21 · FY2016 · EB · contact PI
Disease-Specific Integrated Microphysiological Human Tissue Models$827,522
UH3 · FY2015 · TR · contact PI
Matrix assisted cell transplantation of brown fat$419,528
R01 · FY2015 · DK
iPSC Derived Cardiac Microchambers for Embryonic Drug Screening$235,438
R21 · FY2015 · EB · contact PI
Stem Cell Engineering Training Program$127,633
T32 · FY2015 · GM
Disease-Specific Integrated Microphysiological Human Tissue Models$100,000
UH3 · FY2015 · TR · contact PI
Disease-Specific Integrated Microphysiological Human Tissue Models$829,891
UH3 · FY2014 · TR · contact PI
Disease Specific Cardiac Tissue Models$605,351
R01 · FY2014 · HL · contact PI
Matrix assisted cell transplantation of brown fat$418,238
R01 · FY2014 · DK
Stem Cell Engineering Training Program$150,728
T32 · FY2014 · GM
Disease-Specific Integrated Microphysiological Human Tissue Models$771,487
UH2 · FY2013 · TR · contact PI
Disease Specific Cardiac Tissue Models$577,388
R01 · FY2013 · HL · contact PI
Enabling Technologies for hES Cell Self-Renewal$332,565
R01 · FY2013 · HL · contact PI
Multivalent Conjugates for Enhanced Bioactivity of Growth Factor Based Therapies$166,624
R21 · FY2013 · AR · contact PI
Disease-Specific Integrated Microphysiological Human Tissue Models$156,500
UH2 · FY2013 · TR · contact PI
Stem Cell Engineering Training Program$148,810
T32 · FY2013 · GM
Disease-Specific Integrated Microphysiological Human Tissue Models$893,570
UH2 · FY2012 · TR · contact PI
Disease Specific Cardiac Tissue Models$616,515
R01 · FY2012 · HL · contact PI
Enabling Technologies for hES Cell Self-Renewal$352,113
R01 · FY2012 · HL · contact PI
Nanopatterned Surfaces to Control Cell Fate$324,387
R01 · FY2012 · GM · contact PI
Multivalent Conjugates for Enhanced Bioactivity of Growth Factor Based Therapies$209,680
R21 · FY2012 · AR · contact PI
Stem Cell Engineering Training Program$148,810
T32 · FY2012 · GM
Disease Specific Cardiac Tissue Models$627,859
R01 · FY2011 · HL · contact PI
Enabling Technologies for hES Cell Self-Renewal$358,222
R01 · FY2011 · HL · contact PI
Nanopatterned Surfaces to Control Cell Fate$325,671
R01 · FY2011 · GM · contact PI
Stem Cell Engineering Training Program$73,471
T32 · FY2011 · GM
Enabling Technologies for hES Cell Self-Renewal$360,543
R01 · FY2010 · HL · contact PI
Nanopatterned Surfaces to Control Cell Fate$330,138
R01 · FY2010 · GM · contact PI
Novel Tissue-Engineered Treatments for Myopia Control$185,565
R21 · FY2010 · EY
Nanopatterned Surfaces to Control Cell Fate$105,330
R01 · FY2010 · GM · contact PI
Enabling Technologies for hES Cell Self-Renewal$362,039
R01 · FY2009 · HL · contact PI
Nanopatterned Surfaces to Control Cell Fate$334,300
R01 · FY2009 · GM · contact PI
Novel Tissue-Engineered Treatments for Myopia Control$224,240
R21 · FY2009 · EY
Nanopatterned Surfaces to Control Cell Fate$167,840
R21 · FY2006 · EB · contact PI
Nanopatterned Surfaces to Control Cell Fate$210,344
R21 · FY2005 · EB
2005 Biomaterials Gordon Conference$34,120
R13 · FY2005 · DE
Biomimetic Materials Useful for Rehabilitation$376,925
R01 · FY2004 · AR
BIOMIMETIC HYDROGELS FOR BONE REGENERATION$264,229
R01 · FY2004 · AR
Biomimetic Materials Useful for Rehabilitation$365,897
R01 · FY2003 · AR
BIOMIMETIC HYDROGELS FOR BONE REGENERATION$256,531
R01 · FY2003 · AR
Biomimetic Materials Useful for Rehabilitation$355,193
R01 · FY2002 · AR
BIOMIMETIC HYDROGELS FOR BONE REGENERATION$249,061
R01 · FY2002 · AR
Biomimetic Materials Useful for Rehabilitation$372,974
R01 · FY2001 · AR
BIOMIMETIC HYDROGELS FOR BONE REGENERATION$241,807
R01 · FY2001 · AR
BIOMIMETIC HYDROGELS FOR BONE REGENERATION$284,801
R01 · FY2000 · AR